Procter & Gamble Company (The) $PG Shares Purchased by Candriam S.C.A.

Key Points

• Candriam S.C.A. increased its holdings in Procter & Gamble by 4.4%, owning 1,312,540 shares valued at approximately $223.68 million, making it the investor's 8th largest holding.
• During the first quarter, several large institutional investors, including Nuveen LLC and GAMMA Investing LLC, significantly increased their stakes in Procter & Gamble, reflecting overall strong institutional interest in the company.
• Procter & Gamble reported earnings of $1.48 per share, exceeding estimates, with quarterly revenue of $20.89 billion, a 1.7% increase compared to the previous year.

Candriam S.C.A. grew its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 4.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,312,540 shares of the company's stock after buying an additional 54,871 shares during the quarter. Procter & Gamble accounts for approximately 1.4% of Candriam S.C.A.'s holdings, making the stock its 8th largest position. Candriam S.C.A. owned approximately 0.06% of Procter & Gamble worth $223,683,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Sandhill Capital Partners LLC increased its stake in Procter & Gamble by 0.9% in the 1st quarter. Sandhill Capital Partners LLC now owns 39,708 shares of the company's stock worth $6,767,000 after buying an additional 341 shares in the last quarter. TFB Advisors LLC lifted its holdings in shares of Procter & Gamble by 0.6% in the 1st quarter. TFB Advisors LLC now owns 19,678 shares of the company's stock valued at $3,354,000 after acquiring an additional 110 shares during the last quarter. Dorsey & Whitney Trust CO LLC lifted its stake in Procter & Gamble by 1.1% in the first quarter. Dorsey & Whitney Trust CO LLC now owns 56,203 shares of the company's stock worth $9,578,000 after purchasing an additional 611 shares during the last quarter. GM Advisory Group LLC lifted its stake in Procter & Gamble by 0.6% in the first quarter. GM Advisory Group LLC now owns 15,333 shares of the company's stock worth $2,613,000 after purchasing an additional 95 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its stake in shares of Procter & Gamble by 41.7% during the first quarter. T. Rowe Price Investment Management Inc. now owns 10,620 shares of the company's stock valued at $1,810,000 after acquiring an additional 3,126 shares in the last quarter. 65.77% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares of the company's stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CAO Matthew W. Janzaruk sold 319 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $50,169.13. Following the completion of the sale, the chief accounting officer directly owned 1,704 shares in the company, valued at approximately $267,988.08. This represents a 15.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 119,181 shares of company stock worth $18,761,172. Corporate insiders own 0.18% of the company's stock.

Procter & Gamble Trading Down 0.1%

Shares of PG stock traded down $0.2160 during trading hours on Friday, hitting $158.5140. The company had a trading volume of 5,796,582 shares, compared to its average volume of 7,597,930. The stock has a market capitalization of $371.30 billion, a PE ratio of 24.35, a price-to-earnings-growth ratio of 4.19 and a beta of 0.37. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company's fifty day moving average is $156.79 and its 200 day moving average is $162.97.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm's quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. The ex-dividend date was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble's dividend payout ratio is 64.98%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PG. Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. Morgan Stanley set a $180.00 price objective on shares of Procter & Gamble and gave the company an "overweight" rating in a report on Friday, April 25th. Citigroup decreased their target price on shares of Procter & Gamble from $200.00 to $181.00 and set a "buy" rating for the company in a research report on Friday, April 25th. BNP Paribas reiterated an "outperform" rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, Redburn Atlantic downgraded shares of Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price objective for the company. in a research report on Thursday, May 1st. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Procter & Gamble has a consensus rating of "Moderate Buy" and an average target price of $175.94.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.